Xiao Z, Chen W, Du Y, Zeng F, et al. Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single-arm clinical trial. Int J Cancer 2025 Jan 18. doi: 10.1002/ijc.35340.
PMID: 39825777